NCT01460446View on ClinicalTrials.gov

ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?

NACompletedINTERVENTIONAL

Enrollment

218

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DEVICE

Aviva Expert blood glucose meter

DEVICE

Aviva Nano blood glucose meter

Trial Locations (33)

12351

Berlin

13088

Berlin

13597

Berlin

18057

Rostock

45335

Essen

47179

Duisburg

48155

Münster

50858

Köln-Weiden

55469

Simmern

63739

Aschaffenburg

81479

München

82008

Unterhaching

86150

Augsburg

93437

Furth im Wald

01627

Berlin

04103

Leipzig

04808

Wurzen

BB23HH

Blackburn

BH7 7DW

Bournemouth

BD96RJ

Bradford

CH21UL

Chester

PO63LY

Cosham

CV22DX

Coventry

DE223NE

Derby

EX25DW

Exeter

LE15WW

Leicester

HD33EA

Lindley, Huddersfield

TS4 3BW

Middlesbrough

NN15BD

Northampton

NG72UH

Nottingham

S602UD

Rotherham

DN157BH

Scunthorpe

S57AU

Sheffield

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01460446 - ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)? | Biotech Hunter | Biotech Hunter